EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...
Nasdaq

Bausch, Clearside receive U.S. approval for eye injection

Bausch Health Companies Inc and Clearside Biomedical Inc said on Monday they received approval from the U.S. health regulator for their eye injection, giving patients access to a novel treatment for ...
Medscape

Microneedle Developed for Back-of-the-Eye Injections

August 2, 2012 — Using a microneedle to inject drugs into the suprachoroidal space may provide a method for drug delivery to the posterior segment of the eye that is less invasive and more targeted ...
UPI

Some patients may be able to pause eye injections for macular degeneration

Injection medications can save the vision of older people with macular degeneration, but the ongoing regimen is taxing. Now a preliminary study raises the possibility that some patients can safely be ...
Medscape

Eye Injections Cost More Than Payers Think

CHICAGO — Specialists are losing money with every intravitreal injection they administer, regardless of the drug being injected, an investigator warns. Each injection we do costs $127.74 — $1.60 for ...

Eye drug costs hit 'people's enjoyment of life'

A Guernsey resident believes "people's enjoyment in life" is being sacrificed for the financial cost of using a drug that can treat wet age-related macular degeneration (AMD).
AOL

Eyedrop breakthrough could replace painful eye injections for retinal diseases

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.